You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
廣濟藥業(000952.SZ)擬斥5000萬元設立生物技術研究院
格隆匯 01-17 21:21

格隆匯1月17日丨廣濟藥業(000952.SZ)公佈,為整合公司的研發資源,加強研發及技術創新體系建設,擬成立湖北廣濟藥業生物技術研究院有限公司(暫定名,以工商註冊名為準,“研究院”)。

公司名稱:湖北廣濟藥業生物技術研究院有限責任公司(暫定);註冊資本金:5000萬元人民幣;經營範圍:維生素產品的技術創新和其他維生素類產品的研發,天然產物的生物發酵合成以及工業酶產品的研發,醫藥產品中間體、醫藥試劑、體外診斷試劑、營養保健品等研究開發,醫藥技術轉讓,醫藥技術諮詢和醫藥技術服務等。

此次對外投資成立研究院將集中上市公司研發方面的人力、物力、財力資源,強化公司在“生物合成”領域的研發優勢,加大在“化學合成”領域的研發力度,實現公司研發滿足自身需求的同時,發揮市場化運營優勢,激發活力為上市公司創造收益和價值,有利於提高上市公司資源配置效率,有利於研發成果的迅速轉化,有利於加快公司發展。

此次對外投資設立全資子公司屬於現有生產經營範疇,風險相對可控,是公司從長遠戰略出發所做的慎重決策,研究院作為公司的研發平台,定位和作用一是合成生物學領域的基礎研究和工業轉化;二是建立高質量產品開發平台,補充未來的產品管線,為市場研究提供技術基礎。公司擬設立該研究院有利於提升公司經營管理效率,有利於增強公司綜合競爭力,符合公司的戰略發展方向,符合全體股東的利益。公司將組建市場化子公司經營管理團隊,以不斷適應業務要求和市場變化,積極防範和應對各種風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account